Alvotech stock gains on double upgrade at Barclays (ALVO:NASDAQ)
· seekingalpha.com
Alvotech (ALVO) stock gains as Barclays upgrades the company to Overweight from Underweight ahead of key FDA approval decisions. Read more here.
Alvotech (ALVO) traded higher on Wednesday after Barclays upgraded the drugmaker to Overweight from Underweight, citing a compelling risk-reward setup ahead of ...